LBIO (Longevity Biomedical) Interest Expense: $ Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Longevity Biomedical Interest Expense?

Longevity Biomedical LBIO Interest Expense is $ Mil as of . 20.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Longevity Biomedical's interest expense for the six months ended in . 20 was $ 0.00 Mil. Longevity Biomedical does not have enough years/quarters to calculate its interest expense for the trailing twelve months (TTM) ended in . 20.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Longevity Biomedical's Operating Income for the six months ended in . 20 was $ 0.00 Mil. Longevity Biomedical's Interest Expense for the six months ended in . 20 was $ 0.00 Mil. Longevity Biomedical did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Longevity Biomedical  (NAS:LBIO) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Longevity Biomedical's Interest Expense for the six months ended in . 20 was $0.00 Mil. Its Operating Income for the six months ended in . 20 was $0.00 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in . 20 was $0.00 Mil.

Longevity Biomedical's Interest Coverage for the quarter that ended in . 20 is calculated as

Longevity Biomedical had no long-term debt (1).

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Longevity Biomedical Interest Expense Historical Data

* Premium members only.

The historical data trend for Longevity Biomedical's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Biomedical Interest Expense Chart

Longevity Biomedical Annual Data
Trend
Interest Expense

Longevity Biomedical Semi-Annual Data
Interest Expense

Longevity Biomedical Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $ Mil mean?
Longevity Biomedical (LBIO) has a Interest Expense of $ Mil as of . 20. Interest Expense is the amount a company pays on its long-term debt. View historical data on Longevity Biomedical and its competitors.
Is Longevity Biomedical's Interest Expense too high?
Longevity Biomedical's current Interest Expense is $ Mil.
How does Longevity Biomedical's Interest Expense compare to ?
Longevity Biomedical's Interest Expense of $ Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Longevity Biomedical and its competitors. Longevity Biomedical's current Interest Expense is $ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Biomedical stock overvalued right now?
Longevity Biomedical (LBIO) has a current Interest Expense of $ Mil. The current Interest Expense is $ Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For Longevity Biomedical (LBIO), the current Interest Expense is $ Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Biomedical Business Description

Comparable Companies
Address 12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.